Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) EBITDA Margin (2016 - 2026)

Pediatrix Medical (MD) has disclosed EBITDA Margin for 17 consecutive years, with 6.85% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin rose 96.0% to 6.85% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 8.73% through Dec 2025, up 1359.0% year-over-year, with the annual reading at 8.73% for FY2025, 1359.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 6.85% at Pediatrix Medical, down from 14.61% in the prior quarter.
  • The five-year high for EBITDA Margin was 14.61% in Q3 2025, with the low at 30.3% in Q2 2024.
  • Average EBITDA Margin over 5 years is 2.87%, with a median of 5.71% recorded in 2021.
  • The sharpest move saw EBITDA Margin tumbled -3588bps in 2024, then skyrocketed 3877bps in 2025.
  • Over 5 years, EBITDA Margin stood at 13.64% in 2021, then crashed by -57bps to 5.84% in 2022, then plummeted by -524bps to 24.77% in 2023, then soared by 124bps to 5.9% in 2024, then grew by 16bps to 6.85% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 6.85%, 14.61%, and 8.47% for Q4 2025, Q3 2025, and Q2 2025 respectively.